Increased alkaline phosphatase and cystatin C levels have been associated with hyperthyroidism (37, 38), and the group treated by ATDs showed statistically significant increases in these markers, especially compared with the other treatment regimens, where levels were closer to those in controls. This evidence concerns the gene CST3 and hyperthyroidism.